UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Icon
ICLR
$12.7B
| $236K | ﹤0.01% |
+1,400
| New | +$221K |
|
2302
RPC Inc
RES
$1.3B
| $235K | ﹤0.01% |
76,411
+547
| +0.7% | +$1.67K |
|
2303
International Seaways
INSW
$4.57B
| $232K | ﹤0.01% |
14,216
-12,489
| -47% | -$272K |
|
2304
OrthoPediatrics
KIDS
$595M
| $230K | ﹤0.01% |
5,256
-800
| -13% | -$36K |
|
2305
Orthofix Medical
OFIX
$419M
| $229K | ﹤0.01% |
7,170
-7,870
| -52% | -$261K |
|
|
VAL
2306
DELISTED
Valaris plc Class A Ordinary Share
VAL
| $229K | ﹤0.01% |
351,595
+23,125
| +7% | +$13.1K |
|
2307
Boston Omaha
BOC
$436M
| $229K | ﹤0.01% |
+14,300
| New | +$239K |
|
|
AXDX
2308
DELISTED
Accelerate Diagnostics
AXDX
| $227K | ﹤0.01% |
1,500
-1,044
| -41% | -$103K |
|
|
CODX
2309
Co-Diagnostics
CODX
$5.6M
| $226K | ﹤0.01% |
+390
| New | +$178K |
|
|
DCOM
2310
DELISTED
Dime Community Bancshares
DCOM
| $226K | ﹤0.01% |
16,436
+4,364
| +36% | +$63.2K |
|
|
SP
2311
DELISTED
SP Plus Corporation
SP
| $225K | ﹤0.01% |
10,857
+649
| +6% | +$13.4K |
|
2312
Krystal Biotech
KRYS
$9.66B
| $224K | ﹤0.01% |
5,400
-467
| -8% | -$22.5K |
|
2313
Zumiez
ZUMZ
$339M
| $223K | ﹤0.01% |
8,132
-6,920
| -46% | -$157K |
|
2314
National CineMedia
NCMI
$378M
| $221K | ﹤0.01% |
7,441
-505
| -6% | -$15.2K |
|
|
GTT
2315
DELISTED
GTT Communications, Inc.
GTT
| $221K | ﹤0.01% |
27,077
-1,114
| -4% | -$10.1K |
|
|
EIGI
2316
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $221K | ﹤0.01% |
54,801
+31,553
| +136% | +$93.1K |
|
2317
Central Garden & Pet Co
CENT
$2.8B
| $221K | ﹤0.01% |
+7,659
| New | +$206K |
|
2318
Five Point Holdings
FPH
$375M
| $219K | ﹤0.01% |
47,694
-31,637
| -40% | -$159K |
|
|
APLT
2319
DELISTED
Applied Therapeutics
APLT
| $219K | ﹤0.01% |
+6,067
| New | +$254K |
|
|
BMTC
2320
DELISTED
Bryn Mawr Bank Corp
BMTC
| $219K | ﹤0.01% |
7,926
| – | – |
|
2321
Precision BioSciences
DTIL
$207M
| $219K | ﹤0.01% |
+877
| New | +$192K |
|
2322
BancFirst
BANF
$3.8B
| $219K | ﹤0.01% |
+5,400
| New | +$198K |
|
2323
Expro Ltd
XPRO
$1.91B
| $218K | ﹤0.01% |
16,313
+1,231
| +8% | +$16.6K |
|
2324
Hanmi Financial
HAFC
$946M
| $218K | ﹤0.01% |
22,400
-4,759
| -18% | -$46.8K |
|
2325
Tejon Ranch
TRC
$451M
| $217K | ﹤0.01% |
15,069
| – | – |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.